Google has achieved a milestone in machine learning research that will boost the company’s broader ambitions in healthcare. In a paper published today in Nature Medicine, Google researchers present an end-to-end deep learning model that can predict lung cancer comparably or better than human radiologists.
It’s not uncommon to find scalpers at concert halls and sporting events, hawking admission tickets at inflated prices. Chinese hospitals however have been invaded by a more problematic breed of scalper — those who deal in the appointment registration tokens that hospitals use to process patient visits.
Chinese tech giant Tencent’s first attempt in AI healthcare was the Miying platform, which has been a point of pride for CEO Huateng Ma since its 2017 launch. Supported by AI-powered medical imaging technologies, Miying assists doctors with the screening of esophageal cancer, pulmonary nodules, cervical cancer, etc. The platform has been well received in the AI and medical communities, with a fast-expanding market in Chinese top-tier AAA hospitals.
Facebook AI Research (FAIR) and the New York University (NYU) School of Medicine’s Center for Advanced Imaging Innovation and Research (CAI2R) announced today they are sharing a standardized set of AI tools and baselines and MRI data as part of their joint research project fastMRI.
Artificial intelligence can now match or outperform human experts in diagnosis and referral on eye diseases, suggests a new paper from DeepMind. The UK-based, Google-owned research institute today released joint research results with the UK’s Moorfields Eye Hospital and UCL Institute of Ophthalmology, which present a new AI technique in the context of OCT imaging. The paper was published on Nature Medicine’s website.